Les anticorps monoclonaux: une ingénierie technologique au service de l'efficacité thérapeutique
- Author
- ROSSIGNOL, Alexis1 2 ; WATIER, Hervé1 2 3
[1] Université François-Rabelais de Tours, France
[2] CNRS, UMR 6239, équipe « Immunogénomique et anticorps thérapeutiques », Tours, France
[3] CHRU de Tours, France - Issue title
- De la naissance à l'usage thérapeutique des anticorps monoclonaux en onco-hématologie
- Author (monograph)
- ROCHANT, Henri (Editor); PEFFAULT DE LATOUR, Régis (Editor)1
[1] Service d'hématologie greffe de moelle, Hôpital Saint-Louis, Paris, France - Source
Hématologie (Montrouge). 2009, Vol 15, pp 5-13, 9 p ; NS3 ; ref : 47 ref
- ISSN
- 1264-7527
- Scientific domain
- Hematology
- Publisher
- John Libbey Eurotext, Montrouge
- Publication country
- France
- Document type
- Article
- Language
- French
- Keyword (fr)
- Anticancéreux Anticorps monoclonal Efficacité traitement Génie biomédical Homme Hématologie Hémopathie maligne Traitement Cancer
- Keyword (en)
- Antineoplastic agent Monoclonal antibody Treatment efficiency Biomedical engineering Human Hematology Malignant hemopathy Treatment Cancer
- Keyword (es)
- Anticanceroso Anticuerpo monoclonal Eficacia tratamiento Ingeniería biomédica Hombre Hematología Hemopatía maligna Tratamiento Cáncer
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02R Antineoplastic agents / 002B02R03 Immunotherapy
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B19 Hematologic and hematopoietic diseases / 002B19B Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis
- Discipline
- Blood diseases Pharmacological treatments
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 22001388
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Install on your browser
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:99:\"Les anticorps monoclonaux: une ing\u00e9nierie technologique au service de l'efficacit\u00e9 th\u00e9rapeutique\";s:9:\"\u0000*\u0000jtitle\";s:24:\"H\u00e9matologie (Montrouge)\";s:9:\"\u0000*\u0000stitle\";s:24:\"H\u00e9matologie (Montrouge)\";s:7:\"\u0000*\u0000date\";s:4:\"2009\";s:9:\"\u0000*\u0000volume\";s:2:\"15\";s:8:\"\u0000*\u0000issue\";s:0:\"\";s:8:\"\u0000*\u0000spage\";s:1:\"5\";s:8:\"\u0000*\u0000epage\";s:2:\"13\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1264-7527\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"ROSSIGNOL\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Alexis\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:1:{i:0;s:14:\"WATIER, Herv\u00e9\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:3:\"NS3\";s:9:\"\u0000*\u0000btitle\";s:88:\"De la naissance \u00e0 l'usage th\u00e9rapeutique des anticorps monoclonaux en onco-h\u00e9matologie\";s:8:\"\u0000*\u0000title\";s:99:\"Les anticorps monoclonaux: une ing\u00e9nierie technologique au service de l'efficacit\u00e9 th\u00e9rapeutique\";s:8:\"\u0000*\u0000place\";s:9:\"Montrouge\";s:6:\"\u0000*\u0000pub\";s:20:\"John Libbey Eurotext\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:99:\"Les anticorps monoclonaux: une ing\u00e9nierie technologique au service de l'efficacit\u00e9 th\u00e9rapeutique\";s:9:\"\u0000*\u0000jtitle\";s:24:\"H\u00e9matologie (Montrouge)\";s:9:\"\u0000*\u0000stitle\";s:24:\"H\u00e9matologie (Montrouge)\";s:7:\"\u0000*\u0000date\";s:4:\"2009\";s:9:\"\u0000*\u0000volume\";s:2:\"15\";s:8:\"\u0000*\u0000issue\";s:0:\"\";s:8:\"\u0000*\u0000spage\";s:1:\"5\";s:8:\"\u0000*\u0000epage\";s:2:\"13\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1264-7527\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"ROSSIGNOL\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Alexis\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:1:{i:0;s:14:\"WATIER, Herv\u00e9\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:3:\"NS3\";s:9:\"\u0000*\u0000btitle\";s:88:\"De la naissance \u00e0 l'usage th\u00e9rapeutique des anticorps monoclonaux en onco-h\u00e9matologie\";s:8:\"\u0000*\u0000title\";s:99:\"Les anticorps monoclonaux: une ing\u00e9nierie technologique au service de l'efficacit\u00e9 th\u00e9rapeutique\";s:8:\"\u0000*\u0000place\";s:9:\"Montrouge\";s:6:\"\u0000*\u0000pub\";s:20:\"John Libbey Eurotext\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:99:\"Les anticorps monoclonaux: une ing\u00e9nierie technologique au service de l'efficacit\u00e9 th\u00e9rapeutique\";s:9:\"\u0000*\u0000jtitle\";s:24:\"H\u00e9matologie (Montrouge)\";s:9:\"\u0000*\u0000stitle\";s:24:\"H\u00e9matologie (Montrouge)\";s:7:\"\u0000*\u0000date\";s:4:\"2009\";s:9:\"\u0000*\u0000volume\";s:2:\"15\";s:8:\"\u0000*\u0000issue\";s:0:\"\";s:8:\"\u0000*\u0000spage\";s:1:\"5\";s:8:\"\u0000*\u0000epage\";s:2:\"13\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1264-7527\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"ROSSIGNOL\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Alexis\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:1:{i:0;s:14:\"WATIER, Herv\u00e9\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:3:\"NS3\";s:9:\"\u0000*\u0000btitle\";s:88:\"De la naissance \u00e0 l'usage th\u00e9rapeutique des anticorps monoclonaux en onco-h\u00e9matologie\";s:8:\"\u0000*\u0000title\";s:99:\"Les anticorps monoclonaux: une ing\u00e9nierie technologique au service de l'efficacit\u00e9 th\u00e9rapeutique\";s:8:\"\u0000*\u0000place\";s:9:\"Montrouge\";s:6:\"\u0000*\u0000pub\";s:20:\"John Libbey Eurotext\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:99:\"Les anticorps monoclonaux: une ing\u00e9nierie technologique au service de l'efficacit\u00e9 th\u00e9rapeutique\";s:9:\"\u0000*\u0000jtitle\";s:24:\"H\u00e9matologie (Montrouge)\";s:9:\"\u0000*\u0000stitle\";s:24:\"H\u00e9matologie (Montrouge)\";s:7:\"\u0000*\u0000date\";s:4:\"2009\";s:9:\"\u0000*\u0000volume\";s:2:\"15\";s:8:\"\u0000*\u0000issue\";s:0:\"\";s:8:\"\u0000*\u0000spage\";s:1:\"5\";s:8:\"\u0000*\u0000epage\";s:2:\"13\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1264-7527\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"ROSSIGNOL\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Alexis\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:1:{i:0;s:14:\"WATIER, Herv\u00e9\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:3:\"NS3\";s:9:\"\u0000*\u0000btitle\";s:88:\"De la naissance \u00e0 l'usage th\u00e9rapeutique des anticorps monoclonaux en onco-h\u00e9matologie\";s:8:\"\u0000*\u0000title\";s:99:\"Les anticorps monoclonaux: une ing\u00e9nierie technologique au service de l'efficacit\u00e9 th\u00e9rapeutique\";s:8:\"\u0000*\u0000place\";s:9:\"Montrouge\";s:6:\"\u0000*\u0000pub\";s:20:\"John Libbey Eurotext\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:99:\"Les anticorps monoclonaux: une ing\u00e9nierie technologique au service de l'efficacit\u00e9 th\u00e9rapeutique\";s:9:\"\u0000*\u0000jtitle\";s:24:\"H\u00e9matologie (Montrouge)\";s:9:\"\u0000*\u0000stitle\";s:24:\"H\u00e9matologie (Montrouge)\";s:7:\"\u0000*\u0000date\";s:4:\"2009\";s:9:\"\u0000*\u0000volume\";s:2:\"15\";s:8:\"\u0000*\u0000issue\";s:0:\"\";s:8:\"\u0000*\u0000spage\";s:1:\"5\";s:8:\"\u0000*\u0000epage\";s:2:\"13\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1264-7527\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"ROSSIGNOL\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Alexis\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:1:{i:0;s:14:\"WATIER, Herv\u00e9\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:3:\"NS3\";s:9:\"\u0000*\u0000btitle\";s:88:\"De la naissance \u00e0 l'usage th\u00e9rapeutique des anticorps monoclonaux en onco-h\u00e9matologie\";s:8:\"\u0000*\u0000title\";s:99:\"Les anticorps monoclonaux: une ing\u00e9nierie technologique au service de l'efficacit\u00e9 th\u00e9rapeutique\";s:8:\"\u0000*\u0000place\";s:9:\"Montrouge\";s:6:\"\u0000*\u0000pub\";s:20:\"John Libbey Eurotext\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
